0001950047-26-004140.txt : 20260506 0001950047-26-004140.hdr.sgml : 20260506 20260506163036 ACCESSION NUMBER: 0001950047-26-004140 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20260506 DATE AS OF CHANGE: 20260506 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Avalo Therapeutics, Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 26949026 BUSINESS ADDRESS: STREET 1: 1500 LIBERTY RIDGE DRIVE STREET 2: SUITE 321 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 1500 LIBERTY RIDGE DRIVE STREET 2: SUITE 321 CITY: WAYNE STATE: PA ZIP: 19087 FORMER COMPANY: FORMER CONFORMED NAME: Cerecor Inc. DATE OF NAME CHANGE: 20111102 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: VARKI PAUL CENTRAL INDEX KEY: 0001677896 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O AVALO THERAPEUTICS, INC. STREET 2: 1500 LIBERTY RIDGE DRIVE, SUITE 321 CITY: WAYNE STATE: PA ZIP: 19087 144 1 primary_doc.xml 144 0001677896 XXXXXXXX LIVE 0001534120 AVALO THERAPEUTICS, INC. 001-37590 1500 Liberty Ridge Drive, Suite 321 Wayne PA 19087 4105228707 PAUL VARKI Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

92771 1508456.46 22788452 05/06/2026 NASDAQ Common 05/06/2026 Exercise of Stock Options Issuer N 92771 05/06/2026 Cash Y The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale. 05/06/2026 11/12/2025 /s/ Paul Varki